Cite
HARVARD Citation
Yuan, X. et al. (2018). A Kv1.3 channel‐specific blocker alleviates neurological impairment through inhibiting T‐cell activation in experimental autoimmune encephalomyelitis. CNS neuroscience & therapeutics. pp. 967-977. [Online].